Drug interactions
Lanreotide + Linagliptin-metformin
Severity: Moderate
Lanreotide and Linagliptin-metformin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Lanreotide suppresses insulin, glucagon and incretin secretion and can alter glucose regulation, causing either hyperglycemia or hypoglycemia. This may change the requirement for antidiabetic therapy.
What this interaction means in plain words
Lanreotide and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Lanreotide belongs to Endocrine; Linagliptin-metformin belongs to Endocrine.
Why it happens
Somatostatin analogue inhibition of insulin and counter-regulatory hormone secretion alters glycemic control.
What to do
Monitor blood glucose when starting lanreotide or changing its dose, and adjust the antidiabetic regimen accordingly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Lanreotide and Linagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Lanreotide
- Lanreotide + Quinidine Major
- Alogliptin-metformin + Lanreotide Moderate
- Canagliflozin-metformin + Lanreotide Moderate
- Cyclosporin + Lanreotide Moderate
- Dapagliflozin-metformin + Lanreotide Moderate
- Empagliflozin-metformin + Lanreotide Moderate
Frequently asked questions
Can I take Lanreotide with Linagliptin-metformin?
MediHelp rates the interaction as moderate. Lanreotide and Linagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lanreotide suppresses insulin, glucagon and incretin secretion and can alter glucose regulation, causing either hyperglycemia or hypoglycemia. This may change the requirement for antidiabetic therapy.
How serious is the interaction between Lanreotide and Linagliptin-metformin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting lanreotide or changing its dose, and adjust the antidiabetic regimen accordingly.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
